Cargando…
Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642035/ http://dx.doi.org/10.1186/1750-1172-10-S1-P11 |
_version_ | 1782400291248799744 |
---|---|
author | Keohane, Denis Schwartz, Jeffrey Gundapaneni, Balarama Stewart, Michelle Amass, Leslie |
author_facet | Keohane, Denis Schwartz, Jeffrey Gundapaneni, Balarama Stewart, Michelle Amass, Leslie |
author_sort | Keohane, Denis |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4642035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46420352015-11-19 Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial Keohane, Denis Schwartz, Jeffrey Gundapaneni, Balarama Stewart, Michelle Amass, Leslie Orphanet J Rare Dis Poster Presentation BioMed Central 2015-11-02 /pmc/articles/PMC4642035/ http://dx.doi.org/10.1186/1750-1172-10-S1-P11 Text en Copyright © 2015 Keohane et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Keohane, Denis Schwartz, Jeffrey Gundapaneni, Balarama Stewart, Michelle Amass, Leslie Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial |
title | Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial |
title_full | Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial |
title_fullStr | Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial |
title_full_unstemmed | Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial |
title_short | Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial |
title_sort | tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642035/ http://dx.doi.org/10.1186/1750-1172-10-S1-P11 |
work_keys_str_mv | AT keohanedenis tafamidisreducesdiseaseprogressioninpatientswithtransthyretinfamilialamyloidpolyneuropathysupportiveposthocanalysesofapivotaltrial AT schwartzjeffrey tafamidisreducesdiseaseprogressioninpatientswithtransthyretinfamilialamyloidpolyneuropathysupportiveposthocanalysesofapivotaltrial AT gundapanenibalarama tafamidisreducesdiseaseprogressioninpatientswithtransthyretinfamilialamyloidpolyneuropathysupportiveposthocanalysesofapivotaltrial AT stewartmichelle tafamidisreducesdiseaseprogressioninpatientswithtransthyretinfamilialamyloidpolyneuropathysupportiveposthocanalysesofapivotaltrial AT amassleslie tafamidisreducesdiseaseprogressioninpatientswithtransthyretinfamilialamyloidpolyneuropathysupportiveposthocanalysesofapivotaltrial |